These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 23832418)
1. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells. Bourkoula K; Englert C; Giaisi M; Köhler R; Krammer PH; Li-Weber M Int J Cancer; 2014 Jan; 134(2):291-300. PubMed ID: 23832418 [TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells. Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505 [TBL] [Abstract][Full Text] [Related]
3. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells. Han Y; San-Marina S; Yang L; Khoury H; Minden MD Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147 [TBL] [Abstract][Full Text] [Related]
4. WT1 promotes invasion of NSCLC via suppression of CDH1. Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386 [TBL] [Abstract][Full Text] [Related]
5. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells. Elmaagacli AH; Koldehoff M; Peceny R; Klein-Hitpass L; Ottinger H; Beelen DW; Opalka B Haematologica; 2005 Mar; 90(3):326-34. PubMed ID: 15749664 [TBL] [Abstract][Full Text] [Related]
6. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells. Fulda S; Strauss G; Meyer E; Debatin KM Blood; 2000 Jan; 95(1):301-8. PubMed ID: 10607716 [TBL] [Abstract][Full Text] [Related]
7. Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms. Li Y; Wang J; Li X; Jia Y; Huai L; He K; Yu P; Wang M; Xing H; Rao Q; Tian Z; Tang K; Wang J; Mi Y Oncol Rep; 2014 Dec; 32(6):2680-6. PubMed ID: 25310451 [TBL] [Abstract][Full Text] [Related]
8. GATA-1 and GATA-2 binding to 3' enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines. Furuhata A; Murakami M; Ito H; Gao S; Yoshida K; Sobue S; Kikuchi R; Iwasaki T; Takagi A; Kojima T; Suzuki M; Abe A; Naoe T; Murate T Leukemia; 2009 Jul; 23(7):1270-7. PubMed ID: 19212333 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors. Zhang X; Inukai T; Hirose K; Akahane K; Kuroda I; Honna-Oshiro H; Kagami K; Goi K; Nakamura K; Kobayashi M; Endo M; Yagita H; Kurosawa H; Thomas Look A; Honda H; Inaba T; Nakazawa S; Sugita K Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623 [TBL] [Abstract][Full Text] [Related]
10. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170 [TBL] [Abstract][Full Text] [Related]
11. Correlation of Wilms' tumor 1 isoforms with HER2 and ER-α and its oncogenic role in breast cancer. Nasomyon T; Samphao S; Sangkhathat S; Mahattanobon S; Graidist P Anticancer Res; 2014 Mar; 34(3):1333-42. PubMed ID: 24596380 [TBL] [Abstract][Full Text] [Related]
12. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804 [TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor protein Wt1 regulates the Interleukin-10 (IL-10) gene. Sciesielski LK; Kirschner KM; Scholz H; Persson AB FEBS Lett; 2010 Nov; 584(22):4665-71. PubMed ID: 20974136 [TBL] [Abstract][Full Text] [Related]
14. Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes. Montano G; Cesaro E; Fattore L; Vidovic K; Palladino C; Crescitelli R; Izzo P; Turco MC; Costanzo P Hum Mol Genet; 2013 May; 22(9):1771-82. PubMed ID: 23362234 [TBL] [Abstract][Full Text] [Related]
15. Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells. Ullmark T; Montano G; Järvstråt L; Jernmark Nilsson H; Håkansson E; Drott K; Nilsson B; Vidovic K; Gullberg U Biochem Biophys Res Commun; 2017 Jan; 482(4):802-807. PubMed ID: 27889611 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of the WT1 gene expression via TMPyP4 stabilization of promoter G-quadruplexes in leukemia cells. Zidanloo SG; Hosseinzadeh Colagar A; Ayatollahi H; Raoof JB Tumour Biol; 2016 Jul; 37(7):9967-77. PubMed ID: 26815508 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the human thromboxane A2 receptor gene by Wilms' tumor (WT)1 and hypermethylated in cancer (HIC) 1 in prostate and breast cancers. Keating GL; Reid HM; Eivers SB; Mulvaney EP; Kinsella BT Biochim Biophys Acta; 2014 Jun; 1839(6):476-92. PubMed ID: 24747176 [TBL] [Abstract][Full Text] [Related]
18. Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression. Zhu JY; Giaisi M; Köhler R; Müller WW; Mühleisen A; Proksch P; Krammer PH; Li-Weber M Cell Death Differ; 2009 Sep; 16(9):1289-99. PubMed ID: 19373244 [TBL] [Abstract][Full Text] [Related]
19. Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines. Anuchapreeda S; Tima S; Duangrat C; Limtrakul P Cancer Chemother Pharmacol; 2008 Sep; 62(4):585-94. PubMed ID: 18034345 [TBL] [Abstract][Full Text] [Related]
20. Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells. Krug U; Yasmeen A; Beger C; Bäumer N; Dugas M; Berdel WE; Müller-Tidow C Int J Oncol; 2009 Jan; 34(1):129-36. PubMed ID: 19082485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]